Moderate riskFDA DrugClass II

Shoolin Pharma Chem sildenafil citrate USP recalled for CGMP deviations

The FDA identified Current Good Manufacturing Practice (CGMP) deviations during an inspection of Shoolin Pharma Chem LLP, a supplier of sildenafil citrate USP—an active pharmaceutical ingredient used in prescription compounding. One lot (SDC2505001) distributed nationwide has been recalled due to these manufacturing control issues.

From the FDA notice · Read the official notice ↗

What to do

  1. If you are a pharmacy or compounding facility that received this lot, stop using it and contact your supplier for instructions.
  2. Do not dispense or compound medications using this material.
  3. Report any adverse events to the FDA MedWatch program.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
SILDENAFIL CITRATE USP, 1.00KG, 1.00KG-bag Net Wt. Rx only " For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-08.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 5 products — see all of them.

Details

Units affected
25 KG, 25 X 1.00 KG bags
Illnesses reported
None reported
Manufactured in
408 B/H Ratnamani Tubes, Block/Survey No; Nr Maruti Inox, Kadi, India
Classification
Class II
Recall number
D-0763-2026

In the FDA's words

Description
SILDENAFIL CITRATE USP, 1.00KG, 1.00KG-bag Net Wt. Rx only " For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-08. CGMP Deviations:Noted during FDA inspection Lot: SDC2505001, Date of Expiry: April 30, 2030. Distribution: Distributed Nationwide in the USA Affected quantity: 25 KG, 25 X 1.00 KG bags
Hazard
CGMP Deviations:Noted during FDA inspection

5 products in this recall

Shoolin Pharma sildenafil and tadalafil powders recalled for manufacturing violations

Shoolin Pharma Chem LLP is recalling five bulk powder products, sildenafil citrate and tadalafil in 100-gram, 500-gram, and 1-kilogram sizes, sold for prescription compounding only. The recall was triggered by manufacturing practice (CGMP) deviations found during an FDA inspection, and no injuries have been reported. The products were distributed nationwide.

The agency lists each product separately. Check every one you might have.

Related topics

OtherDrugsSold nationwideMore from FDA Drug